{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T14:12:37Z","timestamp":1777126357452,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,12]],"date-time":"2027-02-12T00:00:00Z","timestamp":1802390400000},"content-version":"am","delay-in-days":407,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.japh.2025.102983","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:23:46Z","timestamp":1762331026000},"page":"102983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association between state policies enabling pharmacist-led human immunodeficiency virus pre-exposure prophylaxis and need for human immunodeficiency virus prevention: An ecological analysis"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9471-5749","authenticated-orcid":false,"given":"Christina","family":"Chandra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8283-7887","authenticated-orcid":false,"given":"Chante","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry N.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie D.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.japh.2025.102983_bib2","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S1473-3099(14)70847-3","article-title":"Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study","volume":"14","author":"Grant","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.japh.2025.102983_bib3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2101016","article-title":"Cabotegravir for HIV prevention in cisgender men and transgender women","volume":"385","author":"Landovitz","year":"2021","journal-title":"N Engl J Med"},{"issue":"5 Suppl 1","key":"10.1016\/j.japh.2025.102983_bib4","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.amepre.2021.05.027","article-title":"Toward greater pre-exposure prophylaxis equity: increasing provision and uptake for Black and Hispanic\/Latino individuals in the U.S","volume":"61","author":"Bonacci","year":"2021","journal-title":"Am J Prev Med"},{"issue":"4","key":"10.1016\/j.japh.2025.102983_bib5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11904-024-00700-5","article-title":"Implementation science of integrating pre-exposure prophylaxis in pharmacist-led services in the United States","volume":"21","author":"Chandra","year":"2024","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"6","key":"10.1016\/j.japh.2025.102983_bib6","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1071\/SH18084","article-title":"Implementation of a community pharmacy-based pre-exposure prophylaxis service: a novel model for pre-exposure prophylaxis care","volume":"15","author":"Tung","year":"2018","journal-title":"Sex Health Online"},{"issue":"10","key":"10.1016\/j.japh.2025.102983_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz365","article-title":"Acceptability and feasibility of a pharmacist-led human immunodeficiency virus pre-exposure prophylaxis program in the Midwestern United States","volume":"6","author":"Havens","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.japh.2025.102983_bib8","doi-asserted-by":"crossref","unstructured":"Miller TA, Halza K, Hovis Z. Implementation of pharmacist-led HIV pre-exposure prophylaxis management to increase access to care at an academic internal medicine practice. J Am Coll Clin Pharm. doi:10.1002\/jac5.1667","DOI":"10.1002\/jac5.1667"},{"issue":"Supplement_2","key":"10.1016\/j.japh.2025.102983_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz360.1143","article-title":"1280. A Pharmacist-led PrEP program at the epicenter of the HIV epidemic in Atlanta; our experience","volume":"6","author":"Smith","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.japh.2025.102983_bib10","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s10461-021-03494-4","article-title":"Pharmacy-based interventions to increase use of HIV pre-exposure prophylaxis in the United States: a scoping review","volume":"26","author":"Zhao","year":"2022","journal-title":"AIDS Behav"},{"issue":"8","key":"10.1016\/j.japh.2025.102983_bib11","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/OLQ.0000000000001017","article-title":"Iowa TelePrEP: a public-health-partnered telehealth model for human immunodeficiency virus preexposure prophylaxis delivery in a rural state","volume":"46","author":"Hoth","year":"2019","journal-title":"Sex Transm Dis"},{"issue":"1","key":"10.1016\/j.japh.2025.102983_bib12","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.japh.2019.06.021","article-title":"Implementation of pre-exposure prophylaxis at a community pharmacy through a collaborative practice agreement with San Francisco department of public health","volume":"60","author":"Lopez","year":"2020","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"1","key":"10.1016\/j.japh.2025.102983_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/apc.2019.0235","article-title":"A pharmacist-led, same-day, HIV pre-exposure prophylaxis initiation program to increase PrEP uptake and decrease time to PrEP initiation","volume":"34","author":"Khosropour","year":"2020","journal-title":"AIDS Patient Care STDs"},{"issue":"4","key":"10.1016\/j.japh.2025.102983_bib14","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.japh.2019.12.003","article-title":"Pharmacy-based pre-exposure prophylaxis support among pharmacists and men who have sex with men","volume":"60","author":"Crawford","year":"2020","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"1","key":"10.1016\/j.japh.2025.102983_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.japh.2020.10.005","article-title":"Support and perceived barriers to implementing pre-exposure prophylaxis screening and dispensing in pharmacies: examining concordance between pharmacy technicians and pharmacists","volume":"61","author":"Hopkins","year":"2021","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"7","key":"10.1016\/j.japh.2025.102983_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.26028","article-title":"Examination of HIV preexposure prophylaxis need, availability, and potential pharmacy integration in the Southeastern US","volume":"6","author":"Harrington","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.japh.2025.102983_bib17","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1177\/1060028016653608","article-title":"The continuum of pharmacist prescriptive authority","volume":"50","author":"Adams","year":"2016","journal-title":"Ann Pharmacother"},{"issue":"5","key":"10.1016\/j.japh.2025.102983_bib18","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.japh.2023.06.025","article-title":"Revisiting the continuum of pharmacist prescriptive authority","volume":"63","author":"Adams","year":"2023","journal-title":"J Am Pharm Assoc (2003)"},{"key":"10.1016\/j.japh.2025.102983_bib21","author":"Verdin"},{"key":"10.1016\/j.japh.2025.102983_bib24","author":"Valdez"},{"key":"10.1016\/j.japh.2025.102983_bib26","author":"Wiener"},{"issue":"10","key":"10.1016\/j.japh.2025.102983_bib28","doi-asserted-by":"crossref","DOI":"10.2196\/23173","article-title":"A data visualization and dissemination resource to support HIV prevention and care at the local level: analysis and uses of the AIDSVu public data resource","volume":"22","author":"Sullivan","year":"2020","journal-title":"J Med Internet Res"},{"issue":"9","key":"10.1016\/j.japh.2025.102983_bib29","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.2019.1343","article-title":"Ending the HIV epidemic","volume":"321","author":"Fauci","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.japh.2025.102983_bib32","author":"Hufstetler"},{"key":"10.1016\/j.japh.2025.102983_bib36","article-title":"Pharmacist prescribing models for HIV pre-exposure and post-exposure prophylaxis","volume":"58","author":"Adams","year":"2023","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.japh.2025.102983_bib39","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.japh.2021.08.001","article-title":"An observational survey assessing the extent of PrEP and PEP furnishing in San Francisco bay area pharmacies","volume":"62","author":"Bellman","year":"2022","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"1","key":"10.1016\/j.japh.2025.102983_bib40","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3390\/clinpract13010025","article-title":"Empowering Tennessee pharmacists to initiate PrEP using collaborative pharmacy practice agreements","volume":"13","author":"Cernasev","year":"2023","journal-title":"Clin Pract"},{"key":"10.1016\/j.japh.2025.102983_bib41","author":"Peyton"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319125006624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319125006624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T16:56:28Z","timestamp":1771520188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319125006624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1544319125006624"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2025.102983","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between state policies enabling pharmacist-led human immunodeficiency virus pre-exposure prophylaxis and need for human immunodeficiency virus prevention: An ecological analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2025.102983","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102983"}}